Cart
sales@molnova.com
Home - Products - Others - Other Targets - Velaresol

Velaresol

CAS No. 77858-21-0

Velaresol( —— )

Catalog No. M34732 CAS No. 77858-21-0

Velaresol (BW 12C79) is used for the study of tumors, sickle cell anemia and digestive disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 36 In Stock
25MG 56 In Stock
50MG 83 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Velaresol
  • Note
    Research use only, not for human use.
  • Brief Description
    Velaresol (BW 12C79) is used for the study of tumors, sickle cell anemia and digestive disorders.
  • Description
    Velaresol(BW 12C) is a potent left-shifting anti-sickling compound in vitro. Sickle cell disease is an inherited disorder of the hemoglobin molecule. When hemoglobin molecules are exposed to a variety of environments, the red blood cell hemoglobin polymerizes, twists, and morphs into a sickle shape.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    77858-21-0
  • Formula Weight
    238.24
  • Molecular Formula
    C12H14O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (524.68 mM; Ultrasonic (<60°C)
  • SMILES
    O=CC=1C(O)=CC=CC1OCCCCC(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fitzharris P, et al. The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve. Br J Clin Pharmacol. 1985 Apr;19(4):471-81. ?
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • UCL 2077

    UCL 2077 is a subtype-selective blocker of the epilepsy-associated KCNQ channels and it also is a selective slow-afterhyperpolarization channel blocker.

  • CPYPP

    CPYPP is an inhibitor of DOCK2-Rac1 interaction. CPYPP binds to DOCK2 DHR-2 domain and inhibits the guanine nucleotide exchange factor (GEF) activity of DOCK2DHR-2 for Rac1 in a dose-dependent manner(IC50 : 22.8 μM).

  • TP0586532

    TP0586532 is effective against carbapenem-resistant Klebsiella pneumoniae and does not pose a cardiovascular risk.

Sign In Join Free